Form ARS LIGAND PHARMACEUTICALS For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ligand closes $700M convertible notes offering due 2031
- Windward Risk Managers Announces Approved Rate Decreases for Edison and Florida Peninsula Policies
- Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
